DR. RICHARD LOTTENBERG, MD
Osteopathic Medicine at Archer Rd, Gainesville, FL
License number
Florida ME39598
Category
Osteopathic Medicine
Type
Hematology
Address
Address
2
1600 SW Archer Rd, Gainesville, FL 32610
PO Box 918025, Orlando, FL 32891
PO Box 918025, Orlando, FL 32891
Phone
(352) 273-7382
(352) 392-8530 (Fax)
(352) 392-8530 (Fax)
Personal information
See more information about RICHARD LOTTENBERG at radaris.comName
Address
Phone
1766 NW 34Th St APT 3, Gainesville, FL 32605
9419 Aston Gardens Ct APT 108, Parkland, FL 33076
Gainesville, FL
10124 Lombardy Dr, Fort Lauderdale, FL 33321
1766 34Th St, Gainesville, FL 32605
Organization information
See more information about RICHARD LOTTENBERG at bizstanding.comRichard Lottenberg MD
1600 SW Archer Rd #2, Gainesville, FL 32610
Industry:
Internist
Phone:
(352) 392-3261 (Phone), (800) 749-7424 (Phone)
Richard Lottenberg
Categories:
Physicians & Surgeons
Professional information
Dr. Richard Lottenberg - MD (Doctor of Medicine)
Specialties:
Hematology
Certifications:
Hematology, 1984, Internal Medicine, 1978
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
University Of Florida HEM and ONC
1600 SW Archer Rd, Gainesville 32610
Adult HEM ONL Davis Cancer Pvln
2000 SW Archer Rd, Gainesville 32608
Shands Hospital at the University of Florida
1600 West Archer Rd, Gainesville 32608
University Of Florida HEM and ONC
1600 SW Archer Rd, Gainesville 32610
Adult HEM ONL Davis Cancer Pvln
2000 SW Archer Rd, Gainesville 32608
Shands Hospital at the University of Florida
1600 West Archer Rd, Gainesville 32608
1600 SW Archer Rd, Gainesville 32610
Adult HEM ONL Davis Cancer Pvln
2000 SW Archer Rd, Gainesville 32608
Shands Hospital at the University of Florida
1600 West Archer Rd, Gainesville 32608
University Of Florida HEM and ONC
1600 SW Archer Rd, Gainesville 32610
Adult HEM ONL Davis Cancer Pvln
2000 SW Archer Rd, Gainesville 32608
Shands Hospital at the University of Florida
1600 West Archer Rd, Gainesville 32608
Education:
Medical School
University Of Florida College Of Medicine
Graduated: 1975
University Of Florida College Of Medicine
Graduated: 1975
Richard Lottenberg, Gainesville FL
Specialties:
Internal Medicine, Hematology, Hematology & Oncology
Work:
Shands Cancer Center
2000 SW Archer Rd, Gainesville, FL 32608 Malcom Randall Vamc Emergency Dept.
1601 SW Archer Rd, Gainesville, FL 32608
2000 SW Archer Rd, Gainesville, FL 32608 Malcom Randall Vamc Emergency Dept.
1601 SW Archer Rd, Gainesville, FL 32608
Education:
University of Florida (1975) Internal Medicine
Richard Lottenberg, Gainesville FL
Specialties:
Hematologist
Address:
1600 Sw Archer Rd, Gainesville, FL 32610
Education:
University of Florida, College of Medicine - Doctor of Medicine*
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine*, American Board of Internal Medicine Sub-certificate in Hematology (Internal Medicine)*
Professor At University Of Florida
Location:
Gainesville, Florida Area
Industry:
Higher Education
Experience:
University of Florida (Educational Institution; 10,001 or more employees; Higher Education industry): Professor, (-)
Bacterial Plasmin Receptors As Fibrinolytic Agents
US Patent:
5237050, Aug 17, 1993
Filed:
May 15, 1990
Appl. No.:
7/524411
Inventors:
Michael D. P. Boyle - Whitehouse OH
Richard Lottenberg - Gainesville FL
Christopher Broder - Rockville MD
Gregory Von Mering - Gainesville FL
Richard Lottenberg - Gainesville FL
Christopher Broder - Rockville MD
Gregory Von Mering - Gainesville FL
Assignee:
University of Florida Research Foundation, Inc. - Alachua FL
International Classification:
C07K 1500, A61K 3900
US Classification:
530350
Abstract:
The subject invention concerns novel methods and compositions for thrombolytic therapy. More specifically, a receptor with high affinity for plasmin has been characterized, purified, cloned, and expressed. This receptor can be used in combination therapies where it is administered prior to, concurrently with, or after a plasminogen activator. Also, this receptor can be bound to plasmin and administered to humans or animals in need of fibrinolytic activity. Additionally, the invention pertains to a novel immobilized form of plasmin which advantageously accumulates at the point where antifibrinolytic activity is needed.
Bacterial Plasmin Receptors As Fibrinolytic Agents
US Patent:
6136323, Oct 24, 2000
Filed:
Jul 11, 1994
Appl. No.:
8/273247
Inventors:
Michael D. P. Boyle - Whitehouse OH
Richard Lottenberg - Gainesville FL
Christopher Broder - Rockville MD
Gregory Von Mering - Gainesville FL
Richard Lottenberg - Gainesville FL
Christopher Broder - Rockville MD
Gregory Von Mering - Gainesville FL
Assignee:
University of Florida Research Foundation, Inc. - Gainesville FL
International Classification:
A61K 3900, A61K 3902, A61K 3909, C07K 100
US Classification:
4242341
Abstract:
The subject invention concerns novel methods and compositions for thrombolytic therapy. More specifically, a receptor with high affinity for plasmin has been characterized, purified, cloned, and expressed. This receptor can be used in combination therapies where it is administered prior to, concurrently with, or after a plasminogen activator. Also, this receptor can be bound to plasmin and administered to humans or animals in need of fibrinolytic activity. Additionally, the invention pertains to a novel immobilized form of plasmin which advantageously accumulates at the point where antifibrinolytic activity is needed.
Bacterial Plasmin Receptors As Fibrinolytic Agents
US Patent:
5328996, Jul 12, 1994
Filed:
Aug 10, 1992
Appl. No.:
7/928462
Inventors:
Michael D. P. Boyle - Whitehouse OH
Richard Lottenberg - Gainesville FL
Christopher Broder - Rockville MD
Gregory Von Mering - Gainesville FL
Richard Lottenberg - Gainesville FL
Christopher Broder - Rockville MD
Gregory Von Mering - Gainesville FL
Assignee:
University of Florida Research Foundation, Inc. - Gainesville FL
International Classification:
C07H 1700
US Classification:
536 231
Abstract:
The subject invention concerns novel methods and compositions for thrombolytic therapy. More specifically, a receptor with high affinity for plasmin has been characterized, purified, cloned, and expressed. This receptor can be used in combination therapies where it is administered prior to, concurrently with, or after a plasminogen activator. Also, this receptor can be bound to plasmin and administered to humans or animals in need of fibrinolytic activity. Additionally, the invention pertains to a novel immobilized form of plasmin which advantageously accumulates at the point where antifibrinolytic activity is needed.